Filters
Product Type
- 27
General
HIV
HIV
Specialties
Speakers
Newest
Showing results 1 - 20 of 27
- DateApril 1, 2020HIV/AIDS: STRATEGIES FOR AN ENDGAME
Moderator
Bruce D. Walker, MDRagon Institute of MGH, MIT and HarvardPanelists
Myron S. Cohen, MDUniversity of North Carolina at Chapel HillBetsy Herold, MDAlbert Einstein College of MedicineJulie McElrath, MD, PhDFred Hutchinson Cancer Research Center (FHCRC)Gary Nabel, MD, PhDSanofiFreeStandard Price - DateSeptember 6, 2019ENDING THE HIV/AIDS PANDEMIC: FOLLOW THE SCIENCE - ANTHONY S…
Speaker
Anthony S. Fauci, MDNIAID, National Institutes of HealthFreeStandard Price - DateSeptember 6, 2019TOWARDS AN HIV VACCINE: A SCIENTIFIC JOURNEY
Speaker
Anthony S. Fauci, MDNIAID, National Institutes of HealthFreeStandard Price - DateSeptember 6, 2019Recorded during the Keystone Symposia meeting:
Speaker
Till Schoofs, MDThe Rockefeller UniversityFreeStandard Price Deciphering the molecular basis of unusually high neutralization resistance in a tier 3 HIV-1 strain
DateSeptember 6, 2019DECIPHERING THE MOLECULAR BASIS OF UNUSUALLY HIGH NEUTRALIZATION RESISTANCE IN A TIER 3 HIV-1 STRAINSpeaker
Thandeka Moyo, PhDUniversity of Cape TownFreeStandard Price- DateSeptember 6, 2019Recorded during the Keystone Symposia meeting:
Speaker
Karolinska InstitutetFreeStandard Price - DateSeptember 6, 2019Recorded during the Keystone Symposia meeting:
Speaker
Thomas B. Kepler, PhDBoston UniversityFreeStandard Price - DateSeptember 6, 2019Recorded during the Keystone Symposia meeting:
Speaker
Karolinska InstitutetFreeStandard Price - DateSeptember 6, 2019Recorded during the Keystone Symposia meeting:
Speaker
Thumbi Ndung’u, BVM, PhDUniversity of KwaZulu-NatalFreeStandard Price - DateSeptember 6, 2019Recorded during the Keystone Symposia meeting:
Speaker
Elise Landais, PhDIAVI Neutralizing Antibody CenterFreeStandard Price - DateSeptember 6, 2019VACCINE HUMORAL IMMUNITY, IMMUNE CORRELATES AND MECHANISTIC INSIGHTS
Speaker
Georgia Tomaras, PhDDuke Human Vaccine Institute,FreeStandard Price - DateSeptember 6, 2019PROFILING PROTECTIVE ANTIBODY RESPONSES
Speaker
Margaret E. Ackerman, PhDPrincipal Investigator , Thayer School of Engineering at Dartmouth CollegeFreeStandard Price - DateSeptember 6, 2019A BROADLY NEUTRALIZING ANTIBODY FROM AN ELITE NEUTRALIZER TARGET A NOVEL SITE AT THE GP120-GP41 INTERFACE
Speaker
Marit J. van Gils, PhDAcademic Medical Center, University of Amsterdam, the NetherlandsFreeStandard Price - DateSeptember 6, 2019NOVEL THERAPEUTIC INTERVENTIONS IN THE TARGETING OF THE HIV CELL RESERVOIR
Speaker
Lausanne University HospitalFreeStandard Price - DateSeptember 6, 2019AAV-EXPRESSED ECD4-LG AS AN HIV-1 VACCINE ALTERNATIVE
Speaker
Michael Farzan, PhDThe Scripps Research InstituteFreeStandard Price - DateSeptember 6, 2019IMPORTANCE OF CD8 T CELL RESPONSES TARGETING VARIABLE EPITOPES IN SIV
Speaker
University of Wisconsin-MadisonFreeStandard Price - DateSeptember 6, 2019STRUCTURAL STUDIES OF HIV-1 INFECTION
Speaker
Pamela J. Bjorkman, PhDCalifornia Institute of TechnologyFreeStandard Price - DateSeptember 6, 2019HIV VACCINES: PATH TO EFFICACY
Moderator
Gabriella Scarlatti, MD, PhDGlobal HIV Vaccine EnterprisePanelists
FreeStandard Price - DateSeptember 6, 2019Recorded during the Keystone Symposia meeting:
Speaker
Maria Blasi, PhDDuke University Medical CenterFreeStandard Price - DateJune 12, 2019BACKGROUND: The prevalence of infection with the trematode Schistosoma mansoni (Sm) exceeds 50% in many regions of sub-Saharan Africa, and there are ecologic and epidemiologic links with HIV acquisition…
Speaker
Sergey Yegorov, PhDUniversity of TorontoFreeStandard Price